--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About BNTX20260220C105
Biological Technology
BioNTech SE was established on June 2, 2008. The company combines decades of pioneering research in immunology, cutting-edge therapeutic platforms, and various patient analysis and bioinformatics tools to develop individualized immunotherapies for cancer and other diseases. The company utilizes powerful new therapeutic mechanisms, utilizes a variety of biological targets, harnesses the power of each patient's immune system, and addresses the unique molecular characteristics of each patient's underlying disease.
